MedEdTalks - Cardiology
By Vindico Medical Education
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Vindico Medical Education
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 15
Reviews: 0
Episodes: 33
Description
MedEdTalks Cardiology is an accredited educational podcast for providers to learn more about treating patients with Cardiology diseases/disorders. Discover all content and topics by visiting mededtalks.com.
| Episode | Date |
|---|---|
|
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Alan Brown: Lp(a) – What You Need to Know
|
Mar 14, 2025 |
|
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. James Underberg: Familial Hypercholesterolemia – Risk Assessment and Treatment
|
Feb 28, 2025 |
|
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Peter Toth: PCSK9 Inhibition
|
Jan 15, 2025 |
|
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Thomas Dayspring: Perils of Hypertriglyceridemia
|
Dec 16, 2024 |
|
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Christie Ballantyne: CETP Inhibition
|
Nov 15, 2024 |
|
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Michael Davidson: Assessing Cardiovascular Risk
|
Oct 31, 2024 |
|
sGC Modulators in HFrEF: MOA, Clinical Evidence, With Drs. IIeana Pina and Javed Butler
|
Aug 23, 2023 |
|
Updated Guidelines Recommendations for the Management of HFrEF and Worsening HF, With Drs. Ileana Pina and Shelley Zieroth
|
Aug 23, 2023 |
|
Burden of HFrEF and Worsening HF, With Drs. Ileana Piña and Javed Butler
|
Aug 23, 2023 |
|
Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera
|
Jun 02, 2022 |
|
Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub
|
Jun 02, 2022 |
|
The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera
|
Jun 02, 2022 |
|
The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub
|
Jun 02, 2022 |
|
Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll
|
Apr 27, 2022 |
|
Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll
|
Apr 27, 2022 |
|
Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner
|
Apr 27, 2022 |
|
Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner
|
Apr 27, 2022 |
|
PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner
|
Apr 29, 2021 |
|
Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner
|
Apr 29, 2021 |
|
The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner
|
Apr 29, 2021 |
|
Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner
|
Apr 29, 2021 |
|
Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt
|
Mar 24, 2021 |
|
Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar
|
Mar 24, 2021 |
|
Patient Identification for Residual Risk Management: Who's At Risk? with Drs. Pamela Morris and Martha Gulati
|
Mar 24, 2021 |
|
Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What's the Risk? with Drs. Pamela Morris and Martha Gulati
|
Mar 24, 2021 |
|
sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler
|
Dec 16, 2020 |
|
The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler
|
Dec 16, 2020 |
|
sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam
|
Dec 16, 2020 |
|
Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam
|
Dec 16, 2020 |
|
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Blood Pressure Control and Optimizing Care Coordination and Medication Management
|
Jan 08, 2020 |
|
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Reducing CV Risk in Patients With Diabetes – A Discussion on the Latest Data
|
Jan 08, 2020 |
|
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; The Interplay Between T2DM and CV Risk – Implications for Patients
|
Jan 08, 2020 |
|
MedEd Talks in Cardiology - Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists
|
Jan 08, 2020 |